DNA Synthesizer Market To Reach $1,032.7 Million By 2033

August 2026 | Report Format: Electronic (PDF)

DNA Synthesizer Market Growth & Trends

The global DNA synthesizer market size is expected to reach USD 1,032.7 million by 2033, expanding at 15.3% CAGR from 2026 to 2033, according to a new report by Grand View Research, Inc. The increasing interest for synthetic DNA in a wide range of applications including drug discovery and development, gene therapy, and genetic research is the key factor driving the demand for synthesizers. In addition, advancements in synthesis technology and automation are anticipated to further fuel the growth of the market. Moreover, various organic and inorganic developments done by market players in terms of development of efficient synthesizers is another factor supporting industry expansion. For instance, K&A Labs GmbH developed H series DNA synthesizers capable of giving maximum yield.

The evolving demand of synthetic nucleic acid across industries is pushing market players to invest in synthesizers. For instance, in April 2022 Ansa Biotechnologies raised USD 68 million to launch a customizable DNA synthesis service. Moreover, these funding has helped the company to strengthen its gene synthesis capabilities. Similarly, in June 2022 DNA Script raised USD 88.32 million to bring rapid synthesis platform to the lab. This funding supported the commercial launch of the company’s benchtop DNA synthesizers.

The industry is highly competitive, with market players emphasizing on developing new and innovative synthesizers that can give faster and more efficient nucleic acid synthesis capabilities. For instance, in September 2022, Codex DNA, Inc. announced the commercial release and first shipment of BioXp 9600 system, a new high throughput platform developed to revolutionize synthetic biology workflows. In addition, collaborations and partnerships between companies are becoming increasingly common, as companies seek to leverage each other's capabilities and strengths to foster growth and innovation in the market.

Furthermore, exponential rise in demand for DNA synthesizers and other synthesis platforms in pharmaceutical and biotechnological companies have driven the market to a significant extent. Also, rising R&D activities, supportive government legislation, and an increase in the demand for novel therapeutic regimens for rare diseases are supporting industry’s growth.

key Request a free sample copy or view report summary: DNA Synthesizer Market Report

DNA Synthesizer Market Report Highlights

The benchtop DNA synthesizers segment accounted for the largest market share of 73.5% in 2025 and is expected to witness the fastest growth during the forecast period, driven by increasing preference for compact, user-friendly, and cost-efficient platforms that enable researchers to perform DNA synthesis within their own laboratories.
The drug discovery & development segment accounted for the largest market share, at 48.0% in 2025, driven by the increasing use of DNA synthesizers in therapeutic research, advancements in synthesis technologies, and the growing adoption of high-throughput screening approaches.
The pharmaceutical & biotechnology companies segment dominated the market in 2025, accounting for a revenue share of 52.4%, driven by the increasing use of synthetic DNA in drug discovery, genetic therapies, and precision medicine development. Growing demand for advanced synthesis platforms that enable faster and more efficient therapeutic research is further supporting segment growth.